Adaptive Biotechnologies (FRA:1HM) FFO


FRA:1HM Adaptive Biotechnologies Corp FRA:1HM
67 GF Score
Price €18.27
GF Value €8.67
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Adaptive Biotechnologies FFO?

FFO (Funds from operations) only applies to REITs.

FRA:1HM
67GF Score
Adaptive Biotechnologies Corp FRA:1HM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Adaptive Biotechnologies (FRA:1HM) Overvalued in 2026?

Based on GuruFocus' analysis, Adaptive Biotechnologies stock appears to be overvalued. The current stock price of €18.27 is trading 110.7% above its estimated GF Value™ of €8.67. GuruFocus considers Adaptive Biotechnologies to be Significantly Overvalued.

Key valuation signals for FRA:1HM:

  • FFO:
  • GF Value™: €8.67 vs. price of €18.27 (110.7% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the FRA:1HM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adaptive Biotechnologies Business Description

Other Exchanges ADPT:USA
Address 1165 Eastlake Avenue East, Seattle, WA, USA, 98109
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
67GF Score

Get the complete analysis for FRA:1HM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.27
Price
€8.67
GF Value